X

Biotechnology

Wockhardt Ltd Q3FY24; 0% rise in Revenue

Wockhardt is a global pharmaceutical and biotechnology organization engaged in manufacturing finished dosage formulations, injectables, biopharmaceuticals, orals and topicals (creams…

Laurus Labs Ltd Q3FY24; 89% fall in Profits

Founded in 2005, Laurus Labs is a research-driven pharmaceutical and biotechnology company having a global leadership position in select Active…

Syngene International Ltd Q3FY24; 2% rise in Profits

Syngene (established in 1993) as a Biocon subsidiary is India's first Contract Research Organization (CRO) which expanded later to be…

Laurus Labs Limited Q3 FY24 Earnings Conference Call Insights

Key highlights from Laurus Labs Limited (LAURUSLABS) Q3 FY24 Earnings Concall Business Performance Gross margins remained resilient at over 52%…

Laurus Labs Limited Q2 FY24 Earnings Conference Call Insights

Key highlights from Laurus Labs Limited (LAURUSLABS) Q2 FY24 Earnings Concall Q2 FY24 Results Revenue declined 22% year-on-year to INR1,224…

Syngene International Ltd Q2FY24; 14% rise in Profits

Syngene (established in 1993) as a Biocon subsidiary is India's first Contract Research Organization (CRO) which expanded later to be…

Wockhardt Ltd Q1FY24; 8% rise in Revenue

Wockhardt is a global pharmaceutical and biotechnology organization engaged in manufacturing finished dosage formulations, injectables, biopharmaceuticals, orals and topicals (creams…

Shilpa Medicare Ltd Q1FY24; 50% fall in Profits

Shilpa Medicare is engaged in the business of high quality Active Pharmaceuticals Ingredients (APIs), Intermediates, Formulations, New Drug delivery system,…

Panacea Biotec Q4FY23 Earnings Story

Panacea Biotec was set up in the year 1984, under the name of Panacea Drugs Private Limited and was publicly…

Panacea Biotec Q4FY23; 8% Fall in Revenues

Panacea Biotec Ltd.’s revenue in Q4FY23 rose 13% to ₹ 12,557 crores. Consolidated Profit After Tax came at ₹ 4,320…